Lytix Biopharma AS (DE:6BG) has released an update.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Lytix Biopharma AS is set to unveil its Q2 2024 financial results in a live webcast on August 29, 2024, featuring insights from CEO Øystein Rekdal and CFO Gjest Breistein. The Norwegian immuno-oncology leader invites questions in advance for the subsequent Q&A session and will provide access to a recorded version of the presentation on their website.
For further insights into DE:6BG stock, check out TipRanks’ Stock Analysis page.
